We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.21B
AUM Growth
+$158M
Cap. Flow
+$11.5M
Cap. Flow %
0.95%
Top 10 Hldgs %
38.56%
Holding
345
New
37
Increased
103
Reduced
110
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 18.58%
2 Healthcare 9.87%
3 Consumer Discretionary 9.58%
4 Financials 8.26%
5 Industrials 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTM
301
DELISTED
Arcadium Lithium plc
ALTM
$82K 0.01%
+19,036
New +$95.5K
CERS icon
302
Cerus
CERS
$433M
$72.8K 0.01%
38,500
SANW
303
DELISTED
S&W Seed Co
SANW
$72.1K 0.01%
7,842
-658
-8% -$6.72K
PSEC icon
304
Prospect Capital
PSEC
$1.11B
$70.1K 0.01%
12,700
+1,000
+9% +$5.75K
BEEM icon
305
Beam Global
BEEM
$24.2M
$68K 0.01%
+10,000
New +$68.2K
CHPT icon
306
CALL
ChargePoint
CHPT
$143M
0
CDE icon
307
Coeur Mining
CDE
$16B
$56.5K ﹤0.01%
15,000
FGNX
308
FG Nexus Inc
FGNX
$41.9M
$55.2K ﹤0.01%
+320
New +$55.1K
RCG
309
RENN Fund
RCG
$21.3M
$47.4K ﹤0.01%
30,000
MPT
310
CALL
Medical Properties Trust
MPT
$2.75B
0
ARTW icon
311
Arts-Way Manufacturing Co
ARTW
$11.2M
$45.9K ﹤0.01%
21,855
PIM
312
Franklin Master Intermediate Income Trust
PIM
$150M
$35.2K ﹤0.01%
11,000
GSIT icon
313
GSI Technology
GSIT
$233M
$34K ﹤0.01%
+10,000
New +$28.9K
OPK icon
314
Opko Health
OPK
$978M
$20.4K ﹤0.01%
17,000
-12,500
-42% -$12.5K
ACTG icon
315
Acacia Research
ACTG
$447M
-15,000
Closed -$54.8K
ALB icon
316
Albemarle
ALB
$14B
-44,986
Closed -$7.65M
CNNE icon
317
Cannae Holdings
CNNE
$655M
-15,000
Closed -$280K
DAN icon
318
Dana Inc
DAN
$2.97B
-11,500
Closed -$169K
EL icon
319
Estee Lauder
EL
$30.6B
-13,278
Closed -$1.92M
GSST icon
320
Goldman Sachs Access Ultra Short Bond ETF
GSST
$1.58B
-27,911
Closed -$1.39M
HAYW icon
321
Hayward Holdings
HAYW
$3.28B
-22,000
Closed -$310K
INFL icon
322
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.51B
-1,144,443
Closed -$34.8M
IWM icon
323
iShares Russell 2000 ETF
IWM
$81.5B
-10,419
Closed -$1.84M
JPST icon
324
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
-15,449
Closed -$775K
K
325
DELISTED
Kellanova
K
-7,347
Closed -$437K

Similar funds

Shufro Rose & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Shufro Rose & Co held 345 positions worth $1.21B, up 15% from $1.05B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Shufro Rose & Co's Q1 2024 filing shows 37 new, 103 increased, 110 reduced and 29 closed positions. Its largest new stake was Moderna: 146,584 shares worth $15.6M. The largest sale was iShares iBonds Dec 2026 Term Corporate ETF, an estimated $41.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Shufro Rose & Co's largest Q1 2024 buy was Moderna: 146,584 shares worth $15.6M.
  • Shufro Rose & Co added most to iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024, an estimated $121M increase.
  • Shufro Rose & Co's biggest Q1 2024 reduction was iShares iBonds Dec 2026 Term Corporate ETF, cutting an estimated $41.5M.
  • Shufro Rose & Co fully exited Horizon Kinetics Inflation Beneficiaries ETF in Q1 2024, selling an estimated $34.8M.
  • Shufro Rose & Co's ten largest holdings make up 39% of its $1.21B portfolio in Q1 2024.
  • Shufro Rose & Co opened 37 new positions and closed 29 in Q1 2024.
  • Shufro Rose & Co's portfolio value rose 15% quarter-over-quarter to $1.21B.

Based on Shufro Rose & Co's 13F filing for Q1 2024, filed 8 May 2024.